| Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties MM Kemp, A Kumar, S Mousa, E Dyskin, M Yalcin, P Ajayan, RJ Linhardt, ... nanotechnology 20 (45), 455104, 2009 | 190 | 2009 |
| Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid M Yalcin, E Dyskin, L Lansing, DJ Bharali, SS Mousa, A Bridoux, ... The Journal of Clinical Endocrinology & Metabolism 95 (4), 1972-1980, 2010 | 141 | 2010 |
| Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts M Yalcin, DJ Bharali, L Lansing, E Dyskin, SS Mousa, A Hercbergs, ... Anticancer research 29 (10), 3825-3831, 2009 | 138 | 2009 |
| Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor SA Mousa, JJ Bergh, E Dier, A Rebbaa, LJ O’Connor, M Yalcin, A Aljada, ... Angiogenesis 11, 183-190, 2008 | 122 | 2008 |
| Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts SA Mousa, M Yalcin, DJ Bharali, R Meng, HY Tang, HY Lin, FB Davis, ... Lung Cancer 76 (1), 39-45, 2012 | 111 | 2012 |
| Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery W Li, M Yalcin, Q Lin, MSM Ardawi, SA Mousa Journal of controlled release 248, 117-124, 2017 | 90 | 2017 |
| Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer DJ Bharali, M Yalcin, PJ Davis, SA Mousa Nanomedicine 8 (12), 1943-1954, 2013 | 86 | 2013 |
| Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide DB Jacoby, E Dyskin, M Yalcin, K Kesavan, W Dahlberg, J Ratliff, ... Anticancer research 30 (1), 39-46, 2010 | 78 | 2010 |
| Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma M Yalcin, DJ Bharali, E Dyskin, E Dier, L Lansing, SS Mousa, FB Davis, ... Thyroid 20 (3), 281-286, 2010 | 73 | 2010 |
| Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles M Yalcin, HY Lin, T Sudha, DJ Bharali, R Meng, HY Tang, FB Davis, ... Hormones and Cancer 4, 176-185, 2013 | 61 | 2013 |
| Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac T Sudha, DJ Bharali, M Yalcin, NHE Darwish, MD Coskun, KA Keating, ... Nanomedicine 12 (3), 195-205, 2017 | 59 | 2017 |
| Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac T Sudha, DJ Bharali, M Yalcin, NHE Darwish, M Debreli Coskun, ... International journal of nanomedicine, 1305-1315, 2017 | 56 | 2017 |
| Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin PG Phillips, M Yalcin, H Cui, H Abdel-Nabi, M Sajjad, R Bernacki, J Veith, ... Anticancer research 31 (2), 411-419, 2011 | 55 | 2011 |
| Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis PJ Davis, HY Lin, T Sudha, M Yalcin, HY Tang, A Hercbergs, JT Leith, ... OncoTargets and therapy, 1619-1624, 2014 | 54 | 2014 |
| Ficus carica Latex Prevents Invasion Through Induction of Let-7d Expression in GBM Cell Lines G Tezcan, B Tunca, A Bekar, M Yalcin, S Sahin, F Budak, G Cecener, ... Cellular and molecular neurobiology 35, 175-187, 2015 | 53 | 2015 |
| Restoration of Blood Pressure by Centrally Injected U-46619, a Thromboxane A2 Analog, in Hemorrhaged Hypotensive Rats: Investigation of Different Brain Areas M Yalcin, V Savci Pharmacology 70 (4), 177-187, 2004 | 47 | 2004 |
| Fluorinated Analogs of Organosulfur Compounds from Garlic (Allium sativum): Synthesis, Chemistry and Anti-Angiogenesis and Antithrombotic Studies E Block, B Bechand, S Gundala, A Vattekkatte, K Wang, SS Mousa, ... Molecules 22 (12), 2081, 2017 | 44 | 2017 |
| The role of centrally injected nesfatin-1 on cardiovascular regulation in normotensive and hypotensive rats MS Yilmaz, B Altinbas, G Guvenc, LG Erkan, O Avsar, V Savci, ... Autonomic Neuroscience 193, 63-68, 2015 | 44 | 2015 |
| Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin T Sudha, M Yalcin, HY Lin, AM Elmetwally, T Nazeer, T Arumugam, ... Cancer letters 350 (1-2), 25-33, 2014 | 40 | 2014 |
| The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor A Rebbaa, F Chu, T Sudha, C Gallati, U Dier, E Dyskin, M Yalcin, ... Anticancer research 29 (11), 4473-4481, 2009 | 37 | 2009 |
Shaker MousaPresident, Vascular Vision Pharmaceuticals CoVerified email at vvpharma.com
